The future of 340B depends on integrating quality, compliance, technology, and pharmacist-led care to improve patient outcomes and strengthen audit readiness.
Abhi Mehta, PharmD, MS, MBA
Advertisement
Articles by Abhi Mehta, PharmD, MS, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Oveporexton for Narcolepsy Type 1
2
Erica Schwartz Confirmed as CDC Director Amid Public Health Crises
3
KRAS-Targeted Peptide Vaccine Generates Durable Responses, Shows Promise in High-Risk Pancreatic Cancer
4
Beyond the Approval: Operationalizing Zongertinib for HER2-Mutant Lung Cancer
5